Login to Chat
#contactcenterworld, @veevasystems, @merck
Barcelona, Spain, April, 201 -- Veeva Systems (NYSE:VEEV) announced that the Healthcare business of Merck has selected Veeva CRM to improve operating efficiency and commercial effectiveness in Europe, Middle East, and Africa (EMEA). Building on the multi-year partnership with Veeva and following its success throughout North America, Latin America, and Asia Pacific, the business is now standardizing on multichannel Veeva CRM globally.
In addition to core Veeva CRM, the Healthcare business of Merck is expanding use of Veeva CLM, Veeva CRM Approved Email, and Veeva CRM MyInsights across the world. These solutions will enable the business to deliver a seamless customer experience across all channels, including face-to-face, email, and web.
"Understanding our customers and delivering them the right information at the right time through the right channel is key to our commercial strategy," said Chetak Buaria, global head of commercial excellence of the Healthcare business at Merck. "We are unifying on a single global CRM solution to deliver on this vision with Veeva as our trusted global partner."
"Veeva is committed to helping life sciences companies drive effective engagement with healthcare professionals," said Paul Shawah, senior vice president of Veeva Commercial Cloud. "We are proud to team with the Healthcare business of Merck on their important mission to bring innovative medicines to market."
#contactcenterworld, @veevasystems, @merck
Posted by Veronica Silva Cusi, news correspondent
Source: https://www.businesswire.com
About Veeva Systems:
Veeva Systems is focussed in cloud-based solutions for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has over 90 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Paris, Beijing, Shanghai, and Tokyo.
About Merck & Co., Inc.:
MSD K.K., a subsidary of Merck.Co., established in October 2010 as a result of two company integration. *
Our main business is develop, import, manufacture and sales of ethical pharmaceuticals and medical devices. No OTC medicines are sold. It is located in Tokyo, Japan.
(# o employee：about 4400, and
# of products： about 100 products)
* Banyu and SPKK were integrated and became MSD K.K. Both companies had over 50 years of operation in Japan.
Published: Tuesday, April 9, 2019
LOGIN WITH YOUR CONTACTCENTERWORLD.COM ACCOUNT
